In general, patients with breast cancer with hyperphosphorylated TUFT1 exhibited an increased rate of lymph node metastasis and reduced OS (Fig. 7E, F), consistent with the consensus that high levels of CIN are related to poor clinical outcome. Here, TUFT1 is linked to breast cancer.